跳至主要内容
临床试验/IRCT20100102002954N26
IRCT20100102002954N26招募中2 期

Comparison of the efficacy of Adalimumab and Methotrexate in cases of moderate to sever of psoriasis, a double-blind clinical trial

Shahroud University of Medical Sciences0 个研究点目标入组 92 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 55 years(—)
性别
All

入选标准

  • Age range 55-15 years;
  • Patients with a definite diagnosis of moderate to severe psoriasis;
  • Having the satisfaction of participating in the project.

排除标准

  • History of severe burns or skin damage;
  • Existence of severe chronic hormonal disorders such as hypothyroidism;
  • History of severe hirsutism;
  • History of topical treatment of psoriasis with drugs and combined solutions in the last six months;
  • History of skin laser in the past year;
  • History of chronic liver and kidney disease;
  • History of hormone therapy (estrogen or testosterone),
  • Pregnancy or lactation,

研究者

相似试验